Articles

With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon.

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 8

A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding

The challenges are surmountable — and worth taking on to help build advantages

A recent industry revenue report found that effective data use is key in pharma, yet underexploited

New tools can help seamlessly integrate sustainability into R&D and production goals

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 1

The industry must understand and mitigate the impact of short- and long-term obstacles

There is a new era of vaccinology in pharma's pipelines

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 25

ADMs allow manufacturers to take charge of supply channels to boost efficiency and flexibility

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 18

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 11

In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation

How pharma can apply tactics from other industries to tackle recent policy cost initiatives

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 4

How pharma companies are solving regulatory challenges with AI-based technology

Pharma innovators are using technology to meet the unique demands of today’s small scale era

This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more

The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 24

A snapshot of the bold CDMOs working to build pharma’s modern treatments

Ergonomic clothing explicitly designed for the industry helps avoid common safety incidents, as well as aid in compliance

With a dedication to advanced technologies, the Texas-based CDMO is helping quickly bring cell and gene therapies from idea to patient

The Indiana-based CDMO is redefining injectable drug manufacturing with community collaboration and technology

The San Francisco-based IDMO says its differentiated technology will allow pharma companies to unlock massive productivity gains in cell therapy — and save the lives of millions...

With a dual mission to serve both patients and the planet, the Switzerland-based CDMO takes on today’s most complex sterile medicines

Four young companies built with intention tackle the future of medicine